Bovine Coronavirus Winter Dysentery

Overview and Taxonomy of Bovine Coronavirus Winter Dysentery

Taxonomic Classification and Phylogenetic Position

Bovine coronavirus (BCoV), the etiological agent of winter dysentery (WD), is a member of the family Coronaviridae, subfamily Coronavirinae, genus Betacoronavirus, and subgenus Embecovirus [13, 30]. Within the Betacoronavirus-1 species, BCoV is classified alongside human coronavirus OC43 (HCoV-OC43), porcine hemagglutinating encephalomyelitis virus (PHEV), equine coronavirus (ECoV), canine respiratory coronavirus (CRCoV), and several wild ruminant coronaviruses [13, 30]. This taxonomic grouping is defined by the presence of a hemagglutinin-esterase (HE) glycoprotein, a distinctive surface protein that, along with the spike (S) glycoprotein, mediates viral attachment and entry [5, 30]. The HE protein is a hallmark of group 2a coronaviruses and plays a critical role in receptor-binding and receptor-destroying enzyme (RDE) activities, facilitating viral spread through mucus-rich environments [5, 29].

Phylogenetic analyses have consistently demonstrated that BCoV isolates cluster into distinct lineages based on geographic origin and temporal emergence. Early molecular studies using the S glycoprotein gene revealed that BCoV strains could be broadly divided into two major clades: the classical enteric lineage (represented by the prototype Mebus strain) and a more diverse group encompassing both respiratory and contemporary enteric strains [3, 11, 26]. More recent comprehensive genomic analyses have refined this classification into at least four major groups: G1 (classical strains such as Mebus and Nebraska), G2 (Asian/USA strains from the early 2000s), G3 (European strains), and G4 (recent Korean isolates and water deer-derived strains) [15, 16]. This grouping is strongly correlated with nucleotide substitution rates, with G4 strains exhibiting the highest evolutionary rates, suggesting ongoing adaptive evolution [15, 16].

Molecular clock analyses estimate that the most recent common ancestor (MRCA) of contemporary BCoV emerged in the 1940s, with the divergence of geographically distinct lineages occurring between the 1960s and 1970s [26]. A recombination event in the S gene, with a breakpoint at approximately nucleotide 1100, is hypothesized to have been a key driver of this genetic divergence [26]. This recombination may have contributed to the emergence of strains with dual enteric and respiratory tropism, a phenomenon now recognized as a hallmark of BCoV pathogenesis [2, 12, 20].

Genetic Diversity and Molecular Epidemiology

The genetic diversity of BCoV is most pronounced in the S glycoprotein gene, particularly within the S1 subunit, which contains the receptor-binding domain (RBD) and a hypervariable region (HVR) [3, 23]. The S1 HVR is a hotspot for nucleotide and amino acid substitutions, insertions, and deletions, which can alter antigenicity and potentially influence tissue tropism [3, 23]. Phylogenetic analysis of the S1 HVR has been instrumental in tracing transmission pathways and identifying circulating genotypes. For instance, Korean WD strains isolated between 2002 and 2003 clustered with respiratory strain OK and enteric strain LY-138, but were distinct from the ancestral Mebus strain, indicating that these strains possessed a genetic property intermediate between respiratory and enteric BCoVs [3]. Similarly, Brazilian BCoV strains associated with WD and calf diarrhea clustered with North American enteric and WD strains, but separately from Korean and respiratory strains, suggesting at least two distinct circulating lineages in Brazil [23].

The HE gene also exhibits significant genetic diversity, with phylogenetic analyses revealing three distinct groups: one containing only respiratory BCoV (RBCV), a second containing a mix of calf diarrhea (CD), RBCV, WD, and enteric BCoV (EBCV) strains, and a third group composed exclusively of Korean WD strains [5]. This third group, which is sharply distinct from other known BCoVs, suggests that Korean WD strains have followed an evolutionary pathway independent from those circulating in North America and Europe [5]. The HE gene is particularly prone to recombination; a landmark study identified a recombinant HE gene in 10 of 13 BCoV strains from Chinese dairy calves, with recombination breakpoints located between the esterase and lectin domains [17]. These recombinant strains shared identical amino acid variants (F181V in the R2-loop and S158A in the R1-loop), indicating a common recombination event that may confer a selective advantage [17].

In contrast, the membrane (M) and envelope (E) proteins are relatively conserved among BCoV strains, reflecting structural constraints that limit their evolution [5]. The M protein, which is the most abundant virion protein, contains four potential O-glycosylation sites in both BCoV and HCoV-OC43, but lacks a signal peptide, suggesting that it may not be exposed to the O-glycosylation machinery in vivo [5]. The nucleocapsid (N) protein is also highly conserved, making it an ideal target for diagnostic assays and vaccine development [6, 7]. A linear B-cell epitope (380YQQQDG385) identified on the N protein is 100% conserved among BCoV strains and is also present in HCoV-OC43 and CRCoV, but not in other betacoronaviruses, highlighting the close evolutionary relationship between these viruses [7].

Global Distribution and Phylogeography

BCoV is endemic in cattle populations worldwide, with seroprevalence rates varying by region and management system. A systematic review and meta-analysis of BCoV prevalence in China reported an overall prevalence of 30.8% (6,136 positive out of 15,838 samples), with the highest rate in South China (60.5%) and the lowest in Central China (15.6%) [9]. In Korea, a nationwide serological survey using the hemagglutination inhibition (HI) test found that 50.0% of 3,029 cattle were seropositive, with regional variation from 38.1% in Gangwon Province to 55.7% in Gyeonggi Province [24]. In Turkey, BCoV RNA was detected in 22.06% of samples from calves with enteric and/or respiratory signs, with the virus identified on 95.7% of sampled farms [27].

Phylogeographic analyses have revealed a pattern of global transmission and spatial segregation. The European and non-European lineages are largely distinct, with little evidence of genetic mixing between them [26]. This segregation suggests that BCoV genetic diversity is a result of a global transmission pathway that occurred during the last century, followed by independent evolution in geographically separated regions [26]. Swedish BCoV strains, for example, showed unexpectedly high homology with Italian strains, indicating that European strains can circulate across national borders [21]. In contrast, Korean BCoVs originated from the USA but have diverged since the 1980s and are now evolving independently, with relatively high nucleotide substitution rates in the S, HE, and N genes [15]. The 2019–2021 Korean variants exhibited the highest nucleotide sequence identity (98.6–99.2%) with water deer (Hydropotes inermis) isolates, suggesting possible interspecies transmission events [16].

Interspecies Transmission and Host Range

BCoV and bovine-like coronaviruses have been detected in a wide range of domestic and wild ruminant species, including water buffalo, sheep, goats, dromedary camels, llamas, alpacas, deer, antelopes, giraffes, and wild goats [13]. Notably, bovine-like CoVs have also been identified in non-ruminant species. An outbreak of WD in a zoo affected Indonesian tapirs (Acrocodia indica), an odd-toed ungulate (Perissodactyla), demonstrating the adaptability of BCoV to new hosts [1]. Genomic characterization of the tapir-derived CoV revealed that it was closely related to BCoVs previously reported in America, further underscoring the lack of strict host barriers [1]. Similarly, BCoV has been isolated from a goat in Pennsylvania, USA, with the complete genome sequence confirming its classification as a bovine-like coronavirus [10]. In European bison (Bison bonasus) in Poland, BCoV-specific antibodies were found in 6.4% of tested animals, with the detected virus showing >98% homology in the RdRp and S genes to BCoV strains from Polish cattle and wild cervids in Italy [28].

The zoonotic potential of BCoV is a subject of ongoing investigation. Historical examples of zoonotic transmission exist, and BCoV shares a close evolutionary relationship with HCoV-OC43, a common cause of the common cold in humans [13, 27]. Phylogenetic analyses have shown that some BCoV strains, particularly those from Turkey, exhibit high nucleotide similarity (98.28–99.14%) with HCoV-4408, a human coronavirus [27]. The identification of a conserved B-cell epitope on the N protein that is 100% identical between BCoV and HCoV-OC43 further supports the hypothesis of a common ancestor and potential for cross-species transmission [7]. However, the zoonotic risk is currently considered low, and the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) continue to monitor BCoV as part of broader coronavirus surveillance efforts, particularly in the context of the COVID-19 pandemic.

Clinical Syndromes and the Absence of Genetic Markers

BCoV is associated with three distinct clinical syndromes: neonatal calf diarrhea (NCD), winter dysentery (WD) in adult cattle, and respiratory infections (bovine respiratory disease complex, BRDC) in cattle of all ages [13, 22, 25]. Despite decades of research, no consistent genetic or antigenic markers have been identified that can reliably discriminate between strains causing these different syndromes [13, 19, 25]. This lack of correlation between genotype and clinical phenotype suggests that host factors (age, immune status, concurrent infections), environmental conditions (stress, housing, nutrition), and viral quasispecies dynamics play a more significant role in determining disease outcome than specific viral genetic determinants [13, 19].

Experimental infections have confirmed that the same BCoV strain can cause both enteric and respiratory disease. A Korean WD strain experimentally inoculated into colostrum-deprived calves induced diarrhea, villous atrophy in the small intestine, crypt hyperplasia in the large intestine, and epithelial damage in the nasal turbinates, trachea, and lungs, with interstitial pneumonia [2]. BCoV antigen was detected in both the intestinal and respiratory tracts, and viral RNA was detected in serum at 3 days post-inoculation, indicating viremia [2]. Similarly, intranasal inoculation of colostrum-fed calves with a BCoV isolate from a diarrheic calf resulted in diarrhea without respiratory signs, but viral RNA was detected in the tonsil, trachea, lung, liver, kidney, abomasum, and both small and large intestines, demonstrating broad tissue tropism [12]. These findings indicate that BCoV initiates replication in the respiratory epithelium and subsequently disseminates to the digestive tract, with no correlation between gross pathology and viral detection [12].

Cross-protection studies have shown that calves infected with a respiratory, calf diarrhea, or WD strain of BCoV are protected from diarrhea upon challenge with a heterologous strain, but subclinical reinfection (detectable only by nested PCR) occurs in the respiratory and enteric tracts [4, 18]. This subclinical shedding is epidemiologically significant, as it may serve as a source of virus transmission to susceptible animals in closed herds [4, 18]. The immunoglobulin A (IgA) coproantibody response at the time of challenge is strongly associated with protection against diarrhea, while serum IgG1 antibodies correlate with virus neutralization titers [4].

Evolutionary Dynamics and Implications for Control

The evolutionary rate of BCoV is estimated to be higher than that of many other RNA viruses, particularly in the S gene, which is under strong selective pressure from host immune responses [15, 16]. The emergence of recombinant HE strains in China and the rapid evolution of Korean G4 strains highlight the potential for BCoV to adapt to new environments and hosts [15, 17]. This genetic plasticity has implications for vaccine development and diagnostic surveillance. Currently available commercial vaccines, such as the BC94 strain used in South Korea, belong to the GI genotype, but phylogenetic analyses indicate that all prevalent circulating strains in Korea belong to the GIIa type [8, 14]. This genotype mismatch may contribute to vaccine failure and underscores the need for regionally updated vaccines [8, 14]. The development of a live attenuated vaccine candidate (KBR-1-p120) derived from a GIIa strain has shown promise, with attenuation achieved through 120 serial passages in cell culture, resulting in 13 amino acid mutations in the S gene and loss of pathogenicity in calves [8].

The World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) have emphasized the importance of One Health surveillance for coronaviruses, given their propensity for interspecies transmission and zoonotic emergence. BCoV, as a betacoronavirus with a broad host range and close genetic relationship to HCoV-OC43, serves as a model for understanding coronavirus evolution, cross-species transmission, and the mechanisms underlying pneumoenteric disease. Continued genomic surveillance, particularly in regions with high livestock density and wildlife interfaces, is essential for early detection of emerging strains and for informing control strategies, including vaccination and biosecurity measures.

Molecular Pathogenesis of Bovine Coronavirus Winter Dysentery

The molecular pathogenesis of Bovine Coronavirus (BCoV)-induced Winter Dysentery (WD) represents a complex, multi-faceted cascade of viral-host interactions that culminates in severe, often hemorrhagic, enterocolitis and systemic disturbance in adult cattle. Unlike neonatal calf diarrhea, where the pathology is largely confined to the immature intestinal tract, WD in adult animals involves a sophisticated interplay of viral tropism, host immune status, and environmental stressors. The virus, a member of the Betacoronavirus-1 species within the subgenus Embecovirus, possesses a unique arsenal of structural and non-structural proteins that dictate its pathobiology, notably its capacity for dual enteric and respiratory tropism, a feature that is central to its transmission and disease progression within a herd [2, 12, 13].

The Molecular Arsenal: Viral Entry and Cellular Tropism

The initial and defining event in BCoV pathogenesis is the attachment and entry into host cells, a process mediated primarily by the heavily glycosylated spike (S) glycoprotein. WD-associated BCoV strains, like their enteric and respiratory counterparts, utilize the S1 subunit of the S protein to bind to specific host cell receptors. While the primary receptor for BCoV remains a subject of investigation, it is known to involve sialic acid residues, particularly 9-O-acetylated sialic acid, which is also the ligand for the hemagglutinin-esterase (HE) protein [13, 39]. The S1 domain, especially its hypervariable region, is under intense selective pressure, and molecular analyses of WD strains from Korea, Israel, and other global regions demonstrate significant genetic clustering and divergence from reference strains like Mebus [3, 11, 31]. Phylogenetic studies of the S1 gene have stratified BCoV into distinct lineages (GI, GIIa, GIIb), with many contemporary WD and calf diarrhea strains clustering within the GIIa group, suggesting a common evolutionary origin for recent virulent enteric strains [8, 14, 15]. Notably, no single, definitive genetic marker within the S gene has been identified that exclusively segregates WD strains from those causing calf diarrhea or respiratory disease, underscoring the concept that the clinical syndrome is a product of both viral genetics and host factors [13, 25].

The HE protein, a second major surface glycoprotein and a hallmark of group 2a coronaviruses, adds another layer of molecular complexity [30]. It possesses both lectin (hemagglutinating) and receptor-destroying enzyme (RDE; esterase) activities. The RDE activity allows the virus to cleave sialic acid receptors, facilitating viral release and preventing viral aggregation, a critical step for efficient cell-to-cell spread and pathogenesis. Genetic characterization of the HE gene from WD isolates, particularly from Korea, has revealed a high degree of variability. Phylogenetic analyses have placed Korean WD strains into a distinct HE cluster, separate from other enteric and respiratory strains, suggesting a unique evolutionary pathway that may influence tissue tropism and pathogenicity [5]. Recombination events in the HE gene, first described in Chinese BCoV strains, have been detected in WD-associated viruses, with breakpoints located between the esterase and lectin domains. These recombinants often carry specific amino acid variants in the R1 and R2 loops (e.g., F181V, S158A), which are critical for sialoglycan binding and could alter hemagglutination profiles and viral fitness in the bovine enteric environment [17].

Dual Tropism and the Pneumo-Enteric Cycle of Pathogenesis

A cornerstone of WD molecular pathogenesis is the virus's dual enteric and respiratory tropism. Experimental infections with WD-derived BCoV strains have definitively shown that the virus replicates first in the upper respiratory tract (nasal turbinates, tonsils, trachea) before disseminating to the gastrointestinal tract [2, 12]. Park et al. (2007) [2] demonstrated that colostrum-deprived calves orally infected with a Korean WD-BCoV strain developed viremia by day 3 post-infection, with viral antigen detected in the epithelium of both the small and large intestines, as well as the nasal turbinates, trachea, and lungs. This was accompanied by dual pathological changes: villous atrophy in the small intestine and interstitial pneumonia in the lungs. More recent studies using intranasal inoculation of seropositive calves have further refined this model, showing that BCoV RNA appears in nasal secretions before it is detected in feces, confirming the respiratory tract as the primary site of replication [12]. This primary replication in the respiratory tract is often subclinical but serves as a critical amplification step, enabling high-titer shedding of the virus into the environment via nasal secretions.

From this respiratory foothold, the virus spreads to the enteric tract. The exact mechanism of this dissemination, whether via the viremic route, as suggested by the detection of viral RNA in serum [2], or via ingestion of shed respiratory secretions, remains debated, but the end result is a profound infection of the mature absorptive epithelial cells (enterocytes) of the small and large intestine. The virus preferentially targets the differentiated enterocytes lining the villi of the small intestine (jejunum, ileum) and the colonocytes of the large intestine (colon and rectum) [12, 37]. The infection is lytic, leading to the sloughing of infected cells, which is directly responsible for the clinical signs of diarrhea and malabsorption.

Molecular Determinants of Hemorrhagic Diarrhea and Systemic Disease

The most distinctive and economically damaging feature of WD is the profuse, often hemorrhagic, diarrhea. The molecular pathogenesis of this hemorrhage is a culmination of local and systemic inflammatory responses. The loss of infected enterocytes leads to a breakdown of the intestinal barrier, exposing the underlying lamina propria. This triggers a massive local inflammatory response, characterized by the infiltration of neutrophils and macrophages. The histopathological hallmarks, villous atrophy, crypt hyperplasia, and necrosis of crypt epithelial cells, are the direct result of this attack [2, 37]. The necrosis of colonic crypt epithelial cells, specifically where BCoV antigen is present, is a key finding in fatal cases of WD, leading to the loss of fluid absorptive capacity and the sloughing of hemorrhagic tissue into the lumen [37].

The hemorrhage itself is likely multifactorial. First, the direct damage to the mucosal microvasculature, possibly exacerbated by viral replication in endothelial cells or the action of inflammatory mediators like tumor necrosis factor-alpha (TNF-α), can lead to focal bleeding. Second, the loss of enterocytes, which are responsible for the synthesis of clotting factors and other regulatory proteins, may contribute to a local coagulopathy. The systemic impact of this intestinal damage is profound. The breakdown of the gut barrier allows for the translocation of bacterial products (e.g., lipopolysaccharide) into the bloodstream, triggering a systemic acute phase response. Chae et al. (2019) [34] documented a significant increase in serum haptoglobin (Hp) levels and monocytosis in post-weaned calves with BCoV-associated diarrhea, indicating a robust systemic inflammatory response. This acute phase reaction is likely responsible for the fever, depression, and dramatic drop in milk production that characterize WD in lactating cows, which can be as much as a 15-30% reduction, persisting for weeks [32, 33, 35, 36].

The Role of Quasispecies and Immune Evasion

BCoV, like all RNA viruses, exists as a quasispecies, a swarm of closely related but genetically distinct variants within a single host [13]. This intrinsic genetic plasticity is likely a critical molecular determinant of WD pathogenesis. Studies comparing the S and HE genes of viruses from different clinical syndromes have failed to identify stable genetic markers, suggesting that the capacity to cause severe WD is not a fixed property of a specific genotype but may emerge from the existing genetic diversity within a herd or host [13, 25]. The high nucleotide substitution rates, particularly in the S gene, allow for rapid adaptation to the host environment, potentially to evade the local immune response or alter receptor binding kinetics [15, 16]. This genetic drift is accelerated in geographically isolated populations, such as those in Korea, which have evolved independently since the 1980s, showing a faster evolutionary rate than European strains [15, 16, 26].

Furthermore, the molecular pathogenesis of WD is intimately linked to the dynamics of the host immune response. Experimental reproduction of WD is most effective in seronegative animals, and fatal cases are often associated with a lack of pre-existing antibodies [4, 37, 38]. The virus is capable of inducing a strong humoral and mucosal immune response, characterized by the production of BCoV-specific IgA in the gut and respiratory tract [4, 36]. However, the ability of the virus to re-infect the respiratory tract of previously exposed, seropositive animals is well documented, as evidenced by BCoV RNA detection via highly sensitive nested PCR following heterologous challenge [18, 36]. This subclinical reinfection of the respiratory tract is a key epidemiological driver of WD, allowing for the maintenance of the virus within a closed herd and its transmission to immunologically naïve adult cows or young calves during periods of stress (e.g., cold weather, parturition) [4, 18]. The interplay between the evolving viral quasispecies and the waning mucosal IgA titers in adult cows creates a window of susceptibility, frequently aligning with the winter season, thus giving the disease its name. This sophisticated molecular dance, governed by the viral spike, HE, and the host's immunological memory, defines the cyclic, explosive nature of Winter Dysentery outbreaks.

Epidemiology and Global Distribution of Bovine Coronavirus Winter Dysentery

Bovine coronavirus (BCoV) is a globally ubiquitous pathogen, and the specific manifestation of winter dysentery (WD) represents a distinct epizootiological entity within the broader BCoV disease spectrum. The epidemiology of BCoV WD is characterized by its high morbidity, rapid within-herd spread, pronounced seasonality in temperate zones, and significant economic consequences, particularly in dairy operations. Understanding the global distribution and transmission dynamics of WD requires a synthesis of seroprevalence data, molecular phylogenetic analyses, and ecological risk factor assessments across diverse production systems and geographies.

Global Seroprevalence and Geographic Ubiquity

BCoV is endemic in cattle populations worldwide, with serological surveys consistently demonstrating widespread exposure. A nationwide sero-epidemiological survey in Korea, utilizing a hemagglutination inhibition (HI) test on 3,029 bovine sera collected in 2005, revealed that 50.0% of individual cattle were seropositive, with regional variation from 38.1% in Gangwon Province to 55.7% in Gyeonggi Province [24]. This mirrors findings from numerous other regions, confirming that subclinical circulation is extensive even in the absence of overt clinical WD outbreaks. A comprehensive systematic review and meta-analysis of BCoV prevalence in China, encompassing 15,838 samples from 57 articles, estimated an overall prevalence of 30.8%, with dramatic regional disparity ranging from 15.6% in Central China to a striking 60.5% in South China [9]. This analysis further identified sample source, detection method, breeding system, and the presence or absence of diarrhea as significant risk factors modulating prevalence [9]. Such data underscore that BCoV is not merely a pathogen of sporadic outbreaks but is a persistently circulating endemic infection in most cattle populations, with clinical WD representing a periodic exacerbation often triggered by specific host, environmental, or viral factors.

Continental and Regional Distribution Patterns

The documented occurrence of BCoV WD spans every continent with significant cattle industries, though the recognition and reporting of the syndrome vary considerably.

North America: The disease has been recognized for decades in the United States and Canada. In Ohio, a seminal case-control study established a robust epidemiological link between herd-level seroconversion to BCoV and the occurrence of WD outbreaks, highlighting that recent herd exposure to BCoV significantly increased the risk of clinical disease [46]. This study also identified critical management risk factors, including housing cattle in tiestall or stanchion barns (as opposed to free-stall facilities) and the use of manure-handling equipment for feed handling, which amplified the population-attributable risk substantially [46]. The virus was first identified in North America in 1972 and has remained a persistent economic concern for the industry [45].

South America: Contrary to earlier assumptions that WD was restricted to temperate Northern Hemisphere regions, numerous outbreaks have been molecularly confirmed in tropical and subtropical South American countries. Brazil has been a focal point for such research. A classical outbreak in a high-production Holstein dairy herd in Brazil, where 138 of 154 lactating cows (90%) developed diarrhea over nine days with three fatalities, was definitively linked to BCoV via semi-nested PCR and RFLP, with all other enteric pathogens ruled out [32]. This case was pivotal in demonstrating that WD is not solely a cold-weather phenomenon. Further studies in Brazil have detected BCoV in outbreaks affecting pasture-fed Nellore beef steers, with 42.9% of diarrheic fecal samples testing positive, marking the first description of WD in adult beef cattle on pasture in a tropical country [44]. An extensive etiological survey of a WD outbreak in São Paulo state detected BCoV in 100% (21/21) of fecal samples from symptomatic cows, solidifying its role as the primary agent [47]. Cuban researchers also reported their first molecular confirmation of BCoV in WD outbreaks, notably observing disease during the summer months, challenging the seasonal nomenclature [41].

Europe: Norway experienced a well-documented regional epidemic of WD during the winter of 2011–2012. A large-scale cohort study utilizing farmer-reported outbreaks (n=224 herds) compared to control herds (n=2,093) quantified the milk production losses, estimating a total loss of 51 liters per cow over a 26-day period, with a peak daily reduction of 3.6 liters (15%) [35]. This study provided concrete evidence of the severe economic ramifications. In Sweden, molecular tracing of BCoV transmission during a regional WD epizootic in Northern Sweden revealed highly similar viral strains, while a contemporaneous circulation of multiple BCoV genotypes was detected in the higher-density cattle populations of Southern and Central Sweden, indicating extensive inter-herd transmission [21]. An outbreak of WD complicated by fatal interstitial pneumonia was reported in a high-production dairy herd in Southern Italy in 2020, with BCoV RNA detected in lungs, small intestine, lymph nodes, liver, and placenta, underscoring the potential for severe respiratory involvement [33]. In Siberia, Russia, a study of BCoV genetic diversity found viral genome in 16.3% of samples from calves with diarrhea and 9.9% from those with respiratory signs, with phylogenetic clustering based on the S gene revealing both European and American-Asian lineages [11]. In Poland, BCoV antibodies were detected in 6.4% of European bison (Bison bonasus), with the detected virus showing high homology to strains from Polish cattle and wild cervids in Italy, highlighting the role of wildlife in the epidemiology of bovine-like coronaviruses [28].

Asia: The Asian continent has been a rich source of molecular epidemiological data on BCoV WD. Israel provided the first molecular characterization of local BCoV strains from WD outbreaks occurring between 2017 and 2021, finding that local strains clustered together but were genetically distant from the reference enteric Mebus strain [31]. Japan reported a complete genome sequence from an adult cow that died from WD in 2020, providing critical data for understanding the pathogenicity of deadly strains [40]. Turkey detected BCoV RNA in 22.06% of samples from calves under six months showing enteric and/or respiratory signs, with the virus identified on 95.7% of sampled farms (45/47), confirming its hyperendemic nature [27]. China has been the subject of intense study. Beyond the meta-analysis data, a specific survey of diarrheic dairy calves from 14 farms across six provinces found an 18.95% BCoV detection rate, with a striking discovery that 10 of 13 characterized strains harbored a recombinant hemagglutinin/esterase (HE) gene, a novel finding for BCoV evolution [17]. A more recent study from the Yanbian region of Northeast China reported the first isolation of a BCoV strain from the area, detecting BCoV RNA in 70% (140/200) of targeted diarrheic calf specimens [42]. The Korean peninsula has provided some of the most detailed evolutionary analyses. Phylogenetic studies of BCoV strains circulating in Korea have revealed a complex evolutionary history. Early Korean WD strains (2002–2003) were shown to possess genetic properties of both enteric and respiratory BCoVs and were distinct from ancestral enteric strains [3]. Analysis of the HE gene of these Korean strains suggested they formed a distinct evolutionary pathway, separate from respiratory, calf diarrhea, and other WD strains [5]. More recent work (2019–2021 variants) has shown that Korean BCoVs originated from USA strains but have diverged since the 1980s and are now undergoing rapid, independent evolution with relatively high nucleotide substitution rates, forming a distinct group (G4) in phylogenetic analyses of the complete S gene [15, 16].

Africa: The detection of BCoV in Cuba [41] represents the first confirmed report in the Caribbean region. While data from mainland Africa is comparatively sparse in the provided literature, the global nature of BCoV circulation and the presence of large cattle populations on the continent suggest that WD is likely under-recognized and under-reported rather than absent.

Seasonality and the "Winter Dysentery" Paradigm

The term "winter dysentery" itself reflects the classical epidemiological observation in the Northern Hemisphere that outbreaks predominantly occur during the late autumn and winter months. The Norwegian epidemic of 2011–2012 is a classic example [35]. However, the paradigm has been fundamentally challenged by reports from tropical and subtropical regions. The definitive diagnosis of BCoV WD outbreaks in Brazil [32, 44, 47] and Cuba [41] during non-winter months, or in the case of Cuba, explicitly during summer, demonstrates that the seasonal pattern is not an inherent biological requirement of the virus but is instead driven by environmental and management factors. Potential mechanisms for winter seasonality in temperate zones include: (1) increased confinement of cattle indoors, facilitating fecal-oral and respiratory transmission; (2) cold stress potentially causing immunosuppression or altering gastrointestinal physiology; (3) survival and transmission of the virus being more efficient in cooler, more humid conditions; and (4) management practices such as feeding ice water, which was hypothesized as a co-factor in some experimental models [43]. The absence of these environmental triggers in tropical climates does not preclude the disease, but it may alter its seasonal pattern. The work in Cuba, where WD was observed during the summer, is a critical piece of evidence [41].

Transmission Dynamics and Within-Herd Epidemiology

The primary mode of BCoV transmission is the fecal-oral route, but the virus also possesses a dual enteric and respiratory tropism, a feature thoroughly documented in experimental infections. A landmark study demonstrated that a Korean WD-BCoV strain, when orally inoculated into colostrum-deprived calves, caused not only enteric pathology (villous atrophy, crypt hyperplasia) but also epithelial damage in the nasal turbinates, trachea, and lungs, with viral antigen detected in all these sites and viremia detected by day 3 post-infection [2]. This dual tropism has profound epidemiological implications. As Saif [25] notes, BCoV is a pneumoenteric virus shed in both feces and nasal secretions. This allows for multiple transmission routes: direct fecal-oral contact, aerosol or droplet transmission during close confinement, and fomite transmission via contaminated feed, bedding, or equipment.

The role of nasal shedding is particularly important for maintaining infection within closed herds. Cross-protection studies have demonstrated that calves recovered from infection with one BCoV strain (respiratory, calf diarrhea, or WD) are protected from diarrhea upon heterologous challenge but can still undergo subclinical reinfection, with BCoV RNA detectable in nasal and fecal swabs only by highly sensitive nested PCR [4, 18]. This phenomenon of subclinical reinfection in immune animals provides a cryptic reservoir for the virus, allowing it to persist endemically within a herd and periodically trigger clinical WD in naive or immunocompromised adult animals. The finding by El-Kanawati et al. [4] that nasal shedding of BCoV persisted after challenge exposure in previously infected calves confirms that the respiratory tract acts as a chronic shedding site, perpetuating transmission cycles.

Experimental reproduction of WD has shed light on age-related differences in susceptibility and clinical expression. Tråvén et al. [36], using the same BCoV strain to infect both lactating cows and milk-fed calves via direct contact, found that seronegative lactating cows developed a more severe clinical syndrome than seronegative calves. The cows exhibited depressed general condition, anorexia, and a marked decrease in milk yield, whereas the calves, while shedding virus and developing diarrhea, remained in better general condition [36]. This suggests that the clinical severity of WD in adult cattle is not merely a function of the viral strain but is significantly modulated by the physiological state of the host, lactation places a high metabolic demand that likely exacerbates the pathological effects of enteric and systemic infection. This epidemiological observation explains why WD is predominantly a disease of adult dairy cows and underscores the critical economic impact of milk loss.

Host Range and Interspecies Transmission: A Broader Epidemiological Landscape

The epidemiology of BCoV WD cannot be considered in isolation from the virus's capacity to infect a wide range of domestic and wild ruminant species, as well as non-ruminant hosts. BCoV and "bovine-like" coronaviruses have been identified in water buffalo, sheep, goats, dromedary camels, llamas, alpacas, deer, wild cattle, antelopes, giraffes, wild goats, and even dogs and humans [13]. A particularly striking example of this adaptability is the documented outbreak of WD associated with a bovine-like CoV affecting captive Indonesian tapirs (Acrocodia indica), an odd-toed non-ruminant ungulate (Perissodactyla) [1]. Genomic characterization revealed the virus was closely related to BCoVs from America, illustrating the remarkable ability of BCoV to cross species barriers and cause clinical enteric disease in distantly related ungulates. The complete genome sequence of a BCoV isolated from a goat in Pennsylvania further confirms that these cross-species infections are not isolated events [10].

This broad host range introduces complexity to the epidemiology of WD. Wild ruminants can act as reservoirs for BCoV, potentially reintroducing the virus to domestic cattle herds, as suggested by the detection of a BCoV in Polish European bison with high homology to strains from cattle and wild cervids [28]. Conversely, the detection of identical BCoV sequences in water deer (Hydropotes inermis) and cattle in Korea underscores potential bidirectional transmission at the wildlife-livestock interface [16]. The zoonotic potential is also a concern; historical evidence suggests zoonotic transmission, and BCoV shares high genetic and antigenic similarity with Human Coronavirus OC43 (HCoV-OC43) and canine respiratory coronavirus (CRCoV). The identification of a linear B-cell epitope on the BCoV N protein that is 100% identical in HCoV-OC43 and CRCoV provides a potential molecular link for cross-species transmission [7]. This One Health perspective is critical for comprehensive surveillance and control strategies.

Genetic Diversity as a Driver of Global Epidemiology

The genetic diversity of BCoV is substantial and is a key factor in its global distribution and the variable clinical presentation of WD. Phylogenetic analyses consistently reveal that BCoV strains do not segregate cleanly by clinical syndrome (enteric vs. respiratory vs. WD) or by geographic origin in a simple manner, but rather form complex clusters reflecting global transmission pathways, historical divergence, and recombination events [3, 13, 22, 25]. A comprehensive global analysis of BCoV evolution estimated that the BCoV ancestor emerged in the 1940s, with two geographically distinct lineages diverging in the 1960s–1970s [26]. This divergence may have been driven by a recombination event in the spike gene, highlighting the importance of recombination in generating new viral variants [26]. The study also found evidence of spatial segregation, with European and non-European lineages showing little genetic mixing, suggesting that long-term global BCoV epidemiology is shaped by historical transmission events rather than contemporary global mixing [26].

Within specific regions, the pattern of genetic evolution can be rapid and independent. Korean BCoV strains, for instance, have been classified into distinct groups (GI through G4) over time, with the more recent G4 strains (including 2019–2021 variants) exhibiting higher nucleotide substitution rates and forming a clade distinct from other Asian and American strains [15, 16]. The identification of a novel BCoV strain with a recombinant HE gene in Chinese dairy calves represents a new dimension of genetic evolution, potentially altering viral attachment or receptor-destroying enzyme activity and thereby affecting host range or tissue tropism [17]. Similarly, analysis of Brazilian BCoV strains suggests they have evolved from a purely enteric tropism to a dual enteric and respiratory tropism [20]. In contrast, the M (membrane) and E (envelope) proteins are highly conserved, suggesting strong structural constraints [5]. This combination of rapid evolution in surface glycoproteins (S and HE) and conservation in internal structural proteins creates a dynamic landscape where antigenic drift and recombination can lead to the emergence of strains capable of causing new epidemic waves of WD, even in populations with pre-existing immunity. The circulation of genetically distinct strains within the same geographic region, as observed in Brazil [23], indicates that multiple lineages can co-circulate

Diagnostic Approaches for Bovine Coronavirus Winter Dysentery

The accurate and timely diagnosis of Bovine Coronavirus (BCoV) as the etiological agent of Winter Dysentery (WD) is paramount for implementing effective control measures, mitigating economic losses, and understanding the complex epidemiology of this globally significant pathogen. The diagnostic landscape for BCoV-WD has evolved considerably, moving from classical virological and serological techniques to highly sensitive molecular and advanced immunological platforms. Given that the clinical presentation of WD, acute, often hemorrhagic diarrhea with a precipitous drop in milk production, can be clinically indistinguishable from other enteropathogens such as Salmonella spp., Bovine Viral Diarrhea Virus (BVDV), or coccidiosis, laboratory confirmation is not merely confirmatory but essential for differential diagnosis [32, 44, 47]. The World Organisation for Animal Health (WOAH) recognizes BCoV as a significant pathogen, and robust diagnostic frameworks are critical for surveillance and trade. This section provides an exhaustive analysis of the diagnostic approaches available for BCoV-WD, from sample collection and classical methods to cutting-edge molecular and serological assays, emphasizing their respective strengths, limitations, and optimal applications in both research and field settings.

Sample Collection and Pre-Analytical Considerations

The foundation of any successful diagnostic endeavor rests upon the quality and appropriateness of the clinical specimen. For BCoV-WD, the primary target is the gastrointestinal tract, making fecal samples the specimen of choice for direct viral detection. However, the dual enteric and respiratory tropism of BCoV, well-documented in experimental infections where the virus first replicates in the upper respiratory tract before disseminating to the gut, suggests that nasal swabs can also be a valuable, albeit less commonly utilized, sample type [2, 12, 18]. In adult cattle with WD, the peak of viral shedding in feces coincides with the onset of clinical diarrhea, making this the optimal window for collection. Samples should be collected from multiple acutely affected animals (ideally 5-10) within the first 24-48 hours of clinical signs, as viral titers decline rapidly during convalescence [38, 43].

The physical state of the feces is informative; samples are typically watery to profuse, often containing frank blood or mucus, reflecting the severe hemorrhagic typhlocolitis characteristic of the disease [37, 40]. For molecular diagnostics (RT-PCR), a small volume (1-5 grams) of feces or a fecal swab placed in a sterile, RNase-free transport medium (e.g., phosphate-buffered saline, viral transport medium) is sufficient. For virus isolation, samples must be collected into a medium containing antibiotics to control bacterial overgrowth and kept cold (4°C) but not frozen if processing is immediate; for longer storage, -80°C is required to preserve viral infectivity, as freezing at -20°C can degrade viral RNA and reduce viability [30, 52]. For serological diagnosis, paired serum samples are essential: an acute-phase sample collected at the onset of clinical signs and a convalescent-phase sample collected 2-4 weeks later. A single serum sample is of limited value for diagnosing an active outbreak, as it only indicates past exposure [46, 53].

Classical Virological Methods: Virus Isolation and Electron Microscopy

Historically, virus isolation (VI) in cell culture was the gold standard for BCoV diagnosis. The virus can be propagated in several cell lines, with human rectal tumor (HRT-18) cells and Madin-Darby bovine kidney (MDBK) cells being the most permissive [8, 14, 54]. The inclusion of trypsin in the culture medium is often critical for successful isolation, as it cleaves the spike (S) glycoprotein, facilitating cell-to-cell fusion and viral entry [54]. Cytopathic effect (CPE) is typically characterized by syncytia formation and cell rounding, but it can be subtle and slow to develop, often requiring multiple blind passages. While VI provides a live virus isolate for subsequent characterization, such as whole-genome sequencing or antigenic analysis [27, 31, 40], it is labor-intensive, time-consuming (days to weeks), and has relatively low sensitivity compared to molecular methods. Furthermore, the presence of antibodies or inhibitory substances in fecal samples can neutralize the virus, leading to false-negative results [45]. Consequently, VI is now largely confined to reference laboratories and research settings rather than routine clinical diagnosis.

Electron microscopy (EM) was another early mainstay for detecting viral particles in fecal samples. The characteristic pleomorphic, enveloped virions with prominent club-shaped surface projections (peplomers) are morphologically distinctive for coronaviruses [39, 48]. Immune electron microscopy (IEM), where specific antiserum is used to aggregate viral particles, enhances sensitivity and specificity [4, 53]. However, EM requires expensive equipment, highly trained personnel, and a relatively high viral load (approximately 10⁶ particles per gram of feces) for reliable detection. Its sensitivity is far inferior to modern molecular techniques, and it cannot differentiate BCoV from other coronaviruses without specific immunolabeling. Thus, EM has been largely superseded by more sensitive and practical methods for routine diagnosis.

Antigen Detection Assays: ELISA and Immunofluorescence

Antigen-capture enzyme-linked immunosorbent assays (ELISAs) have been widely developed and validated for the direct detection of BCoV antigens in fecal and nasal samples. These assays typically utilize monoclonal or polyclonal antibodies directed against conserved viral proteins, most commonly the nucleocapsid (N) protein or the spike (S) protein [4, 18, 38, 53]. The advantages of antigen-capture ELISA include relative simplicity, high throughput, and the ability to provide results within a few hours without the need for specialized molecular equipment. They are particularly useful for large-scale epidemiological surveys and herd-level screening [30, 48].

However, the sensitivity of antigen-capture ELISA is a significant limitation. Studies have demonstrated that its detection limit is substantially lower than that of RT-PCR. For instance, a comparative study found that a one-step RT-PCR was 50 times more sensitive, and a nested PCR was 5,000 times more sensitive than an antigen-capture ELISA for detecting BCoV in nasal swab suspensions [18]. This reduced sensitivity is particularly problematic in adult cattle with WD, where viral shedding can be intermittent and of lower titer compared to neonatal calves. Furthermore, the formation of antigen-antibody complexes in the feces of previously exposed adult animals can interfere with the assay, leading to false-negative results [53]. Therefore, while a positive antigen-capture ELISA result is highly specific and confirms infection, a negative result does not rule out BCoV, especially in adult animals.

Immunofluorescence (IF) assays can be applied to detect BCoV antigens in frozen tissue sections (e.g., intestine, lung) or in nasal epithelial cells collected via swabs [2, 4, 50]. This technique allows for the direct visualization of viral antigen within infected cells, providing spatial context to the infection. It is a powerful tool for pathogenesis studies and post-mortem diagnosis. However, its reliance on specialized fluorescence microscopy, subjective interpretation, and the need for high-quality tissue samples limits its use in routine clinical practice.

Molecular Diagnostics: The Gold Standard of RT-PCR

Reverse transcription polymerase chain reaction (RT-PCR) has unequivocally become the cornerstone of BCoV-WD diagnosis due to its unparalleled sensitivity, specificity, and rapid turnaround time. A plethora of conventional, nested, and real-time RT-PCR assays have been developed, targeting various conserved regions of the BCoV genome, most frequently the nucleocapsid (N) gene, the RNA-dependent RNA polymerase (RdRp) gene, and the spike (S) gene [18, 43, 48, 49, 52].

Conventional RT-PCR amplifies a specific DNA fragment which is then visualized by gel electrophoresis. While sensitive, it is qualitative and requires post-amplification processing, increasing the risk of contamination. Nested PCR, which involves two successive rounds of amplification using two sets of primers, offers even greater sensitivity, capable of detecting as few as 200 TCID₅₀/mL of virus [18]. This extreme sensitivity is crucial for detecting low-level shedding in subclinically infected animals or during the early and late stages of infection [18, 43]. However, the high sensitivity of nested PCR also makes it highly prone to cross-contamination, requiring meticulous laboratory practices.

Real-time RT-PCR (qRT-PCR) has largely replaced conventional and nested PCR in modern diagnostic laboratories. By using fluorescent probes (e.g., TaqMan) or DNA-binding dyes (e.g., SYBR Green), qRT-PCR allows for the simultaneous amplification and quantification of viral RNA in a closed-tube system, eliminating post-amplification handling and dramatically reducing contamination risk [27, 33, 42]. The quantitative nature of qRT-PCR is a major advantage, enabling the determination of viral load, which can be correlated with disease severity, shedding dynamics, and response to intervention. For example, a study using digital RT-PCR (dRT-PCR) demonstrated the ability to quantify BCoV RNA across a wide dynamic range in multiple tissues, providing insights into viral dissemination [12]. The development of multiplex qRT-PCR panels allows for the simultaneous detection and differentiation of BCoV from other common enteric pathogens such as Bovine Rotavirus (BRV), Bovine Viral Diarrhea Virus (BVDV), and Escherichia coli K99, making it an exceptionally powerful tool for differential diagnosis of calf diarrhea and WD [42, 45].

The choice of target gene is critical. The N gene is highly conserved and transcribed in large quantities during infection, making it an ideal target for sensitive detection [18, 43]. The S gene, particularly the S1 subunit, is more variable and is the target of choice for phylogenetic and molecular epidemiological studies, as it can differentiate between strains and track transmission pathways [3, 21, 23, 31]. The hemagglutinin/esterase (HE) gene is also used for genetic characterization and has revealed distinct evolutionary lineages, such as the emergence of recombinant HE strains in China [5, 17].

Serological Diagnosis: Detecting Past Exposure and Immune Response

Serological assays detect antibodies against BCoV in serum or milk, providing evidence of past infection or vaccination. These tests are not useful for diagnosing an acute case of WD in an individual animal, as seroconversion occurs after the onset of clinical signs. However, they are invaluable for herd-level surveillance, epidemiological studies, and vaccine efficacy trials [6, 24, 51].

Virus Neutralization (VN) tests are the historical gold standard for serology, measuring the titer of antibodies capable of neutralizing viral infectivity in cell culture [4, 19, 50]. VN is highly specific and detects functional antibodies, but it is labor-intensive, slow (requiring several days), and requires live virus and cell culture facilities.

Enzyme-linked immunosorbent assays (ELISAs) for antibody detection are far more practical for large-scale testing. Indirect ELISAs (iELISAs) using recombinant viral proteins, particularly the highly immunogenic and conserved N protein, have been developed and validated [6, 7]. These assays are rapid, cost-effective, and can be automated. A recent study developed an iELISA based on a secreted recombinant N protein expressed in CHO cells, demonstrating high sensitivity (94.83% concordance with a commercial kit) and specificity, with no cross-reactivity to other major bovine pathogens like BVDV or BRSV [6]. The identification of specific linear B-cell epitopes on the N protein, such as the highly conserved ³⁸⁰YQQQDG³⁸⁵ motif, offers the potential for developing even more specific peptide-based serological tests [7].

Antibody-capture ELISAs, which detect a rise in specific antibody titers between paired serum samples, are particularly useful for confirming recent infection at the herd level [53]. A four-fold or greater increase in titer between acute and convalescent samples is considered strong evidence of recent exposure. This approach has been used in epidemiological studies to link seroconversion to BCoV with an increased risk of WD outbreaks [46].

Hemagglutination Inhibition (HI) tests exploit the hemagglutinating properties of the BCoV S and HE proteins, which can agglutinate erythrocytes from mice, chickens, or rats [19, 24, 41]. HI is a simple and inexpensive technique that has been used for serological surveys and to detect antigenic differences between strains [19, 24, 55]. However, it is less sensitive and specific than ELISA and VN, and the results can be influenced by non-specific inhibitors in serum.

Advanced and Emerging Diagnostic Technologies

Beyond the established methods, several advanced technologies are expanding the diagnostic toolkit for BCoV. Whole-genome sequencing (WGS) using next-generation sequencing (NGS) platforms is becoming increasingly accessible and affordable. WGS provides the ultimate resolution for characterizing circulating strains, identifying genetic markers associated with virulence or tissue tropism, detecting recombination events, and tracing transmission networks at a local and global scale [1, 10, 26, 40]. For instance, WGS has revealed that BCoV strains from different continents form distinct lineages and that recombination in the S gene has played a key role in viral evolution [26]. This information is critical for understanding the emergence of novel variants and for the rational design of vaccines.

Isothermal amplification assays, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), are gaining interest as potential point-of-care (POC) or "barn-side" diagnostic tools [45]. These methods amplify nucleic acids at a constant temperature, eliminating the need for a thermocycler. They can be rapid (results in under an hour), highly sensitive, and relatively simple to perform, making them ideal for use in field settings or in laboratories with limited infrastructure. While still under development for BCoV, they hold great promise for improving access to rapid diagnostics in remote or resource-limited areas.

Diagnostic Algorithm and Interpretation

Given the strengths and weaknesses of each diagnostic modality, a rational approach to diagnosing BCoV-WD in a herd outbreak is essential. The following algorithm is recommended:

1. Clinical and Epidemiological Suspicion: The sudden onset of profuse, often bloody diarrhea affecting a high proportion of adult cows, accompanied by a dramatic drop in milk yield (15-30%), is highly suggestive of WD [32, 35, 36].
2. Initial Herd-Level Screening: Collect fecal samples from 5-10 acutely affected cows. Submit these for real-time RT-PCR (qRT-PCR) targeting the N gene. This is the most sensitive and rapid method to confirm the presence of BCoV RNA in the herd [42, 45]. A positive result confirms BCoV infection.
3. Differential Diagnosis: If qRT-PCR is negative, or if the clinical picture is atypical, test the same samples for other common enteric pathogens, including Salmonella, BVDV, and coccidia, using appropriate culture, PCR, or microscopic techniques [32, 44, 47].
4. Retrospective Confirmation (Optional): To confirm recent herd exposure, collect paired serum samples (acute and 2-4 weeks convalescent) from a subset of affected and unaffected cows. Test these using an antibody-capture ELISA or VN test. A four-fold or greater rise in titer provides strong serological evidence of recent BCoV infection [46, 53].
5. Molecular Epidemiology (Research/Reference): For tracking the source of an outbreak or understanding local strain diversity, perform S gene sequencing or WGS on RT-PCR-positive samples [21, 23, 31].

In conclusion, the diagnosis of BCoV-WD has evolved from a reliance on slow, insensitive classical methods to a sophisticated paradigm dominated by highly sensitive and specific molecular techniques. Real-time RT-PCR is the current gold standard for rapid and accurate detection of the virus in clinical samples. Serological assays, particularly ELISA, remain indispensable for herd-level surveillance and epidemiological investigations. The integration of these tools, guided by a clear diagnostic algorithm, is essential for the effective management and control of this economically devastating disease. The continued advancement of POC technologies and genomic surveillance will further enhance our ability to detect, track, and ultimately combat BCoV-WD in the future.

Clinical Manifestations and Economic Impact of Winter Dysentery

Clinical Manifestations of Winter Dysentery

Winter dysentery (WD) presents as an acute, highly contagious epizootic of diarrhea in adult cattle, predominantly affecting dairy herds during the colder months. The clinical syndrome is remarkably consistent across geographical regions, though the severity can vary considerably based on host immune status, viral strain pathogenicity, and environmental stressors. The hallmark of a WD outbreak is the sudden onset of profuse, watery diarrhea affecting a large proportion of the adult herd, often with explosive rapidity over a period of 24 to 72 hours [31, 32, 35]. Morbidity is characteristically high, frequently exceeding 80-90% of susceptible animals, while mortality remains low, typically under 2-5%, although fatal cases do occur, particularly in animals with compromised immune status or concurrent infections [32, 57].

Enteric Manifestations

The primary clinical sign is diarrhea, which ranges from watery and fetid to frankly hemorrhagic. The presence of blood in the feces, ranging from streaks of fresh blood to dark, tarry stools, is a pathognomonic feature of WD in adult cattle, distinguishing it from many other enteropathies [31, 40, 44]. In a seminal experimental reproduction study, Tråvén et al. [36] demonstrated that seronegative lactating cows developed profusely watery diarrhea with small amounts of blood in the most severely affected animals. The diarrhea is often accompanied by a marked reduction in appetite and general depression, with affected animals appearing lethargic, dehydrated, and exhibiting a tucked-up abdomen [35, 36]. The onset of diarrhea is frequently preceded by a transient fever, although pyrexia may be absent in some outbreaks [35]. The diarrheic episode typically persists for 3 to 7 days, with clinical recovery occurring over 7 to 15 days, though full physiological recovery, particularly of the intestinal epithelium, may take considerably longer [32, 41].

The pathogenesis underlying the diarrhea is rooted in the dual enteric and respiratory tropism of BCoV. Experimental infections in colostrum-deprived calves have revealed that WD-BCoV strains induce significant pathological changes throughout the gastrointestinal tract. Park et al. [2] demonstrated that oral inoculation with a Korean WD-BCoV strain led to gradual villous atrophy in the small intestine and a progressive increase in crypt depth in the large intestine. These lesions compromise the absorptive capacity of the gut, leading to malabsorptive diarrhea. The hemorrhagic component is attributed to necrosis of crypt epithelial cells in the large intestine, as demonstrated by Natsuaki et al. [37] in a fatal case of WD in an adult cow. In that case, extensive loss of surface epithelial cells and necrosis of crypt epithelial cells in the large intestine were observed, with BCoV antigen specifically localized within these necrotic crypt cells. This targeted destruction of the colonic and cecal epithelium explains the characteristic bloody diarrhea, as the integrity of the mucosal barrier is compromised, leading to hemorrhage into the lumen.

Respiratory and Systemic Involvement

While WD is primarily recognized as an enteric disease, BCoV is a pneumoenteric virus with a well-documented dual tropism. Experimental infections have consistently demonstrated that WD-BCoV strains can infect both the upper and lower respiratory tract, even when administered via the oral route [2, 12]. In calves, Park et al. [2] showed that WD-BCoV inoculation resulted in epithelial damage in nasal turbinates, trachea, and lungs, accompanied by interstitial pneumonia. Viral antigen was detected in the epithelium of these respiratory tissues, confirming active replication. Importantly, respiratory signs in adult cattle during WD outbreaks are often subclinical or mild, manifesting as a transient nasal discharge or cough, but they are epidemiologically significant as nasal shedding of the virus can perpetuate transmission within the herd [4, 18]. However, severe and fatal respiratory disease can occur. Amoroso et al. [33] reported an outbreak of WD in a high-production dairy herd in Italy that was complicated by a severe respiratory syndrome, with 9.6% of animals dying from acute respiratory distress. BCoV RNA was detected in the lungs, mediastinal lymph nodes, and other organs, highlighting the potential for BCoV to cause lethal pulmonary infection resembling severe acute respiratory syndromes.

Systemically, infected animals exhibit a pronounced acute phase response. Chae et al. [34] demonstrated that post-weaned calves with BCoV-associated diarrhea had significantly elevated serum haptoglobin (Hp) concentrations and monocytosis compared to recovered calves. This acute phase response is a non-specific indicator of inflammation and tissue damage, reflecting the systemic impact of the infection. The depression and anorexia observed in adult cows are likely multifactorial, stemming from the combined effects of dehydration, electrolyte imbalance, endotoxemia from a compromised gut barrier, and the systemic inflammatory response [36].

Course of Disease and Mortality

The clinical course in a typical outbreak is acute and self-limiting in most animals. The incubation period is short, ranging from 2 to 5 days following exposure [36]. The diarrhea persists for a few days, after which most animals recover spontaneously. However, the economic impact is profound due to the dramatic drop in milk production. As described by Toftaker et al. [35], the lowest milk yield occurs approximately 2 days after the outbreak is reported, with an average loss of 3.6 L/cow per day (a 15% reduction). While mortality is low, it is not negligible. Fatal cases are often associated with severe hemorrhagic diarrhea leading to profound anemia and hypovolemic shock. Natsuaki et al. [37] described a fatal case in an adult cow that had no detectable serum antibodies against BCoV, suggesting that seronegative animals are at heightened risk for severe, lethal disease. Similarly, Takiuchi et al. [32] reported a 2% mortality rate (3 of 138 affected cows) in a high-production Holstein herd in Brazil. Death can also result from secondary bacterial infections or from the severe respiratory form of the disease [33]. The overall case fatality rate is generally estimated at less than 2%, but this can be higher in naïve herds or when management conditions are poor [57].

Economic Impact of Winter Dysentery

The economic consequences of WD outbreaks are substantial and multifaceted, primarily driven by the precipitous decline in milk production, but also encompassing costs related to treatment, increased culling, reduced reproductive performance, and the long-term impact on herd health. The disease is a significant source of financial loss for dairy operations worldwide, and its impact is often underestimated due to the rapid recovery of most animals.

Milk Production Losses

The most significant and well-documented economic impact of WD is the acute and dramatic reduction in milk yield. The seminal cohort study by Toftaker et al. [35] during a regional WD epidemic in Norway provided robust, large-scale evidence of this effect. Analyzing data from 224 affected herds compared to over 2,000 control herds, they estimated a total loss of 51 liters per cow over a 26-day period spanning from 7 days before to 19 days after the reported outbreak. The nadir of production occurred just 2 days after the outbreak was reported, with an average yield of 19.4 L/cow per day compared to 23.0 L/cow per day seven days before notification, a stark 15% drop. This acute loss is compounded by a prolonged recovery period. Descriptive analysis from the same study indicated that herd milk yield was still reduced four months after the outbreak, suggesting that the physiological insult to the mammary gland and the overall metabolic state of the cow has long-lasting repercussions [35]. Other studies have corroborated these findings, with reports of up to a 30% decrease in milk yield during WD outbreaks [45]. The loss is not merely a temporary dip; it represents a permanent loss of potential production for that lactation.

Milk Composition and Quality

Beyond volume, WD also adversely affects milk composition, which can have further economic implications, particularly for milk pricing and processing. Toftaker et al. [35] found that WD outbreaks were associated with an 11% increase in free fatty acids (FFA) in the milk and a small increase in the fat-to-protein ratio. Elevated FFA levels are indicative of increased lipolysis, which can lead to off-flavors and reduced shelf life of milk, potentially resulting in quality deductions or rejection by processors. The shift in fat-to-protein ratio suggests that cows are entering a state of negative energy balance, a common metabolic consequence of reduced feed intake during illness. This metabolic disruption can impair subsequent reproductive performance and increase the risk of other metabolic disorders like ketosis.

Broader Economic Consequences

The economic burden of WD extends far beyond the milk tank. The high morbidity rate means that a large number of animals require supportive care, including fluid therapy, anti-inflammatories, and antibiotics to control secondary bacterial infections. These treatment costs, along with the increased labor required for sick animal management, can be substantial. Furthermore, the disease can lead to an increased culling rate. Cows that experience a severe drop in production or fail to recover their previous production level may be prematurely removed from the herd, representing a loss of genetic potential and replacement costs.

The impact on young stock is also a critical, often overlooked, component of the economic equation. While WD primarily affects adults, the circulation of BCoV within a herd inevitably leads to infection in calves, causing neonatal diarrhea and respiratory disease [9, 15]. This results in increased calf mortality, stunted growth, and higher veterinary costs for calf rearing [9, 56]. A meta-analysis of BCoV prevalence in China found an overall prevalence of 30.8%, with the highest rates in calves with diarrhea, underscoring the virus's role in perpetuating a cycle of disease and economic loss across all age groups [9]. The combined effect of reduced milk sales, increased treatment costs, higher mortality in young stock, and reduced growth rates in replacement heifers creates a significant cumulative financial burden on the cattle industry [13, 45, 56]. As noted by Vlasova and Saif [13], BCoV is an economically significant pathogen, and the losses associated with WD are a primary driver for the development of effective vaccines and biosecurity protocols. The global nature of this pathogen, with its ability to infect a wide range of ruminants and its potential for interspecies transmission, further elevates its importance from both an economic and a One Health perspective [1, 13, 28].

Transmission Dynamics and Cross-Species Host Range

The transmission dynamics of bovine coronavirus (BCoV) associated with winter dysentery (WD) are governed by a complex interplay of viral shedding patterns, environmental stability, host susceptibility, and management practices. Critically, the ability of BCoV to traverse species barriers, from domestic cattle to a remarkable array of wild and companion animals, and potentially to humans, underscores its significance as a model for studying coronavirus emergence. Understanding these pathways is not merely an academic exercise; it is foundational for designing effective biosecurity protocols and predicting future epizootic risks, as recognized by the World Organisation for Animal Health (WOAH) in its frameworks for emerging infectious disease surveillance.

Fecal-Oral and Respiratory Transmission in Cattle

The primary mode of BCoV transmission within affected herds is the fecal-oral route, driven by the voluminous shedding of virions in diarrheic feces. During acute WD outbreaks, adult cattle can excrete massive quantities of virus, contaminating bedding, feeding troughs, and water sources [31, 32]. However, the pathobiology of BCoV is far more nuanced than a simple enteric pathogen. Seminal experimental studies have definitively established that BCoV exhibits dual enteric and respiratory tropism, even when introduced via the oral route. Colostrum-deprived calves inoculated with a Korean WD strain developed not only intestinal lesions but also epithelial damage in the nasal turbinates, trachea, and lungs, with viral antigen detected concurrently in both the digestive and respiratory tracts [2]. This finding has been corroborated by more recent work utilizing intranasal inoculation of colostrum-fed calves, which demonstrated that viral RNA appears first in nasal swabs before it is detected in feces, suggesting that the respiratory epithelium serves as an initial replication site from which the virus subsequently disseminates to the gastrointestinal tract [12].

This dual tropism has profound implications for transmission dynamics. The shedding of BCoV in nasal secretions provides a mechanism for rapid, aerosol or droplet-mediated spread among concentrated animals, a scenario particularly relevant in modern dairy facilities and during the transport of feedlot cattle [25]. Field investigations have confirmed that respiratory tract reinfections occur even in previously exposed, immune animals, creating a persistent cycle of subclinical shedding that can perpetuate outbreaks within closed herds [4, 18]. The virus’s ability to replicate in both the upper respiratory tract and the intestine means that a single infected animal can contaminate the environment through multiple routes simultaneously, dramatically increasing the force of infection. Indeed, molecular epidemiological studies using S gene sequencing have demonstrated that identical BCoV strains can circulate within a herd for months, moving between age groups and clinical syndromes (diarrhea vs. respiratory disease), thereby blurring the traditional distinction between "calf diarrhea" and "winter dysentery" strains [21, 22].

Environmental Persistence and Management Risk Factors

The persistence of BCoV in the environment is a critical, yet often underappreciated, component of its transmission. BCoV is an enveloped virus that is relatively susceptible to desiccation and common disinfectants; however, in the cold, moist conditions typical of winter, the season for which the disease is named, the virus can remain infectious for extended periods in fecal material and contaminated organic matter. The seasonal clustering of WD outbreaks in temperate regions [32, 39] is likely driven by a combination of lower temperatures that enhance viral stability and the housing of cattle in closer confinement, which facilitates both direct contact and fomite transmission.

Epidemiological investigations have pinpointed specific management practices that significantly amplify transmission risk, providing actionable targets for intervention. A landmark case-control study of Ohio dairy herds identified that the use of common equipment for manure handling and feed preparation was a major independent risk factor, with an adjusted population-attributable risk of 31% [46]. This finding highlights the ease with which BCoV can be mechanically disseminated throughout a facility. Furthermore, housing cattle in tiestall or stanchion barns, where animals are in constant, close proximity, was associated with a higher risk of WD outbreaks compared to free-stall facilities, likely due to increased direct contact and shared airspace [46]. The risk is not uniform across all animals within an affected herd; cow-level analyses revealed that pregnant cattle were significantly less likely to develop clinical WD compared to their non-pregnant herdmates, suggesting a potential protective effect of pregnancy-associated immunomodulation [38]. Collectively, these data underscore that transmission is a multifactorial process where viral biology interacts synergistically with housing density, hygiene protocols, and the physiological state of the host.

Cross-Species Host Range: A Broad and Expanding Pantheon

Perhaps the most compelling aspect of BCoV biology is its extraordinary capacity for cross-species transmission. BCoV and bovine-like coronaviruses have been documented in a phylogenetically diverse range of hosts, challenging the notion that BCoV is a cattle-specific pathogen. This host range includes both domestic and wild ruminants, such as water buffalo, sheep, goats, dromedary camels, llamas, alpacas, white-tailed deer, antelopes, giraffes, and wild goats [13, 25]. The detection and complete genome sequencing of a BCoV from a goat in Pennsylvania [10] and the molecular characterization of BCoV in European bison in Poland [28] confirm that these spillover events are not isolated anomalies but rather a recurring ecological phenomenon. Intriguingly, sequence analysis of Korean BCoV variants from 2019-2020 showed the highest nucleotide identity (98.6%-99.2%) with a strain previously isolated from a water deer (Hydropotes inermis), a wild cervid that shares habitats with cattle in East Asia, suggesting bidirectional transmission between domestic livestock and wildlife [16].

The most dramatic demonstration of BCoV’s adaptive potential came from a recent outbreak of winter dysentery in a zoo that affected multiple species, including the Indonesian tapir (Acrocodia indica) [1]. This case is extraordinary because the tapir is an odd-toed ungulate (Perissodactyla), a taxonomic order that had never before been reported as a host for BCoV. Genomic characterization of the outbreak strain revealed it was closely related to BCoVs from North America, indicating a recent and successful host-jump across a significant phylogenetic barrier [1]. This event illustrates that the molecular determinants of BCoV tropism are not rigidly constrained by host receptor specificity, allowing the virus to infect species far removed from its ancestral bovine host.

Zoonotic Potential and Links to Human Coronaviruses

The question of zoonotic transmission is of paramount importance within the framework of a One Health approach, especially given the close phylogenetic relationship between BCoV and human coronavirus OC43 (HCoV-OC43). Historical and molecular evidence suggests that HCoV-OC43, a common cause of the common cold in humans, may have originated from a bovine coronavirus ancestor following a zoonotic spillover event, possibly in the 1890s [13, 26]. This hypothesis is supported by high sequence homology and shared antigenic epitopes. For instance, a recent study identifying a linear B-cell epitope on the BCoV nucleocapsid protein found that this epitope exhibited 100% identity with the corresponding region in both HCoV-OC43 and canine respiratory coronavirus (CRCoV), while showing remarkably low homology with other betacoronaviruses [7]. This suggests a common evolutionary origin or relatively recent recombination events among these viruses.

Contemporary evidence for ongoing zoonotic risk comes from molecular surveillance. Phylogenetic analysis of BCoV S1 gene sequences from cattle in Türkiye revealed high nucleotide similarity (98.28–99.14%) with HCoV-OC43 strains [27]. Similarly, the seroprevalence of BCoV antibodies in human populations, particularly among cattle workers, has been documented, providing serological evidence of exposure [13]. While BCoV does not currently appear to cause widespread human disease, the existence of these genetic and serological bridges necessitates vigilant surveillance. The Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) have emphasized the importance of monitoring livestock coronaviruses as potential precursors to future human epidemics. The fact that BCoV can so readily adapt to new mammalian hosts, crossing from artiodactyls to perissodactyls, and from ruminants to carnivores (canine CRCoV), demonstrates a genetic plasticity that must be considered a potential public health threat, even if the current risk level is assessed as low.

Prevention, Control, and Management Strategies

The prevention and control of Bovine Coronavirus Winter Dysentery (WD) necessitates a comprehensive, multi-layered strategy that integrates biosecurity, vaccination, immunological management, and robust diagnostic surveillance. Given the significant economic impact of WD, including estimated milk production losses of 51 liters per cow during an outbreak period and a 15% reduction in daily yield at the peak of clinical signs [35], the implementation of effective control measures is not merely a veterinary concern but a critical economic imperative for dairy operations worldwide. The World Organisation for Animal Health (WOAH) recognizes coronaviruses as significant pathogens affecting livestock productivity, and the Food and Agriculture Organization (FAO) emphasizes the importance of integrated disease management in sustainable livestock systems. The following sections provide an exhaustive analysis of the biological mechanisms, epidemiological principles, and practical strategies underpinning the prevention, control, and management of BCoV-associated winter dysentery.

Biosecurity and Management Practices as Foundational Control Measures

The cornerstone of any effective WD control program is the rigorous application of biosecurity protocols designed to interrupt the fecal-oral and respiratory transmission pathways of BCoV. Epidemiological investigations have identified several critical risk factors that directly inform management recommendations. A landmark case-control study of dairy herds in Ohio demonstrated that the use of equipment to handle manure and subsequently handle feed was associated with a 31% population-attributable risk for WD outbreaks, while housing cattle in tiestall or stanchion barns rather than free-stall facilities carried a 53% attributable risk [46]. These findings underscore the biological plausibility of mechanical transmission via fomites and the importance of environmental contamination in disease propagation. The virus is shed in high concentrations in diarrheic feces and, critically, also in nasal secretions, even in subclinically infected animals [4, 18]. This dual shedding pattern means that control strategies must address both enteric and respiratory routes of exposure.

The implementation of strict hygiene protocols is therefore non-negotiable. This includes the segregation of manure handling equipment from feed handling equipment, the use of dedicated boots and clothing for personnel working in affected areas, and the establishment of effective boot baths and vehicle disinfection stations at farm entry points. The high stability of coronaviruses in organic matter necessitates the use of appropriate disinfectants with proven efficacy against enveloped viruses, including sodium hypochlorite, quaternary ammonium compounds, and accelerated hydrogen peroxide. Furthermore, the management of animal flow is critical. Given that BCoV can persist in a herd through reinfection of the respiratory tract in recovered animals, which then serve as a source of virus for susceptible cohorts [4, 18], the isolation of newly introduced animals and the separation of age groups are essential. The observation that WD outbreaks often occur in waves affecting lactating cows while sparing other groups [32] suggests that management practices that commingle different production stages or fail to quarantine sick animals can amplify transmission. The experimental reproduction of WD in seronegative lactating cows through direct contact with an infected calf [36] provides compelling evidence that young stock can serve as a reservoir for adult cow outbreaks, reinforcing the need for age-segregated housing and dedicated caretakers for different production groups.

Vaccination Strategies: Current Approaches and Emerging Technologies

Vaccination remains a central pillar of BCoV prevention, yet the development and deployment of effective vaccines are complicated by the antigenic and genetic diversity of circulating strains, the dual enteric and respiratory tropism of the virus, and the need to induce robust mucosal immunity. Currently, no universally standardized vaccine exists that provides complete protection against all clinical manifestations of BCoV, including WD. However, several vaccine platforms have been investigated with varying degrees of success, and the field is rapidly evolving.

Live Attenuated Vaccines: The traditional approach to BCoV vaccination has involved live attenuated strains, typically derived from enteric isolates and administered orally or intranasally to calves to prevent neonatal diarrhea. The rationale for this approach is that live vaccines can replicate in the intestinal or respiratory mucosa, thereby stimulating local IgA responses that are critical for protection at the portal of entry. Indeed, studies in gnotobiotic and colostrum-deprived calves have demonstrated that IgA coproantibodies at the time of challenge are associated with protection against diarrhea [4]. However, a significant limitation of many existing live vaccines is that they are based on older, classical strains (e.g., the Mebus strain or the BC94 strain used in South Korea) that belong to the GI genotype, whereas contemporary circulating field strains in many regions, including South Korea, China, and parts of Europe, belong to the GIIa or other divergent genotypes [8, 14, 15]. This genetic mismatch raises concerns about vaccine efficacy. Phylogenetic analyses have shown that Korean WD strains isolated after 2000 cluster in group GIIa, distinct from the GI group containing the BC94 vaccine strain [14]. Similarly, studies in Siberia have demonstrated that BCoV isolates can be divided into distinct clades based on S gene sequences, with some isolates clustering with European lineages and others with American-Asian lineages, suggesting that a single vaccine strain may not be universally protective [11].

To address this issue, researchers have pursued the development of updated live attenuated vaccine candidates that are antigenically matched to contemporary circulating strains. A notable example is the KBR-1-p120 strain, derived from a GIIa BCoV isolate from a diarrheic calf in South Korea in 2017. This strain was attenuated through 120 serial passages in cell culture, resulting in 13 amino acid mutations in the spike gene. When administered orally to colostrum-deprived calves, the KBR-1-p120 strain induced no diarrhea and only minimal viral RNA shedding in feces, yet it failed to recover pathogenicity after two subsequent passages in calves, indicating stable attenuation [8]. This candidate represents a promising step toward a regionally relevant live vaccine. However, the challenge remains that live vaccines, while effective at inducing mucosal immunity, carry inherent risks of reversion to virulence and may be less suitable for use in immunocompromised animals or during pregnancy.

Inactivated and Subunit Vaccines: Inactivated vaccines offer a safer alternative, but they typically require potent adjuvants to stimulate a robust immune response and often fail to induce strong mucosal IgA responses. Studies evaluating an inactivated KBR-1 strain in mice and goats demonstrated that the choice of adjuvant is critical. The Montanide01 adjuvant generated significantly higher antibody titers (96 ± 13.49 in mice) compared to Carbopol or IMS1313 adjuvants [14]. Furthermore, in a calf challenge model, vaccination with a high dose (10^6.0 TCID50/mL) of inactivated KBR-1 vaccine prevented viral antigen detection in intestinal tissues at 14 days post-challenge and resulted in stable diarrhea scores, whereas a lower dose (10^4.0 TCID50/mL) was less effective [14]. These findings highlight the importance of dose and adjuvant optimization for inactivated vaccines.

Recombinant subunit vaccines represent another avenue of investigation. A pilot study in sheep evaluated a recombinant adenovirus vector expressing the BCoV S and M proteins. The combination vaccine (AdV-BCoV-S+M) induced significantly higher serum neutralizing antibody titers (reaching 1:90 by day 28 post-vaccination) compared to vaccines expressing either protein alone [50]. This approach leverages the immunogenicity of both the spike protein, which is the primary target of neutralizing antibodies, and the membrane protein, which may contribute to cellular immunity. However, this study was limited by a small sample size and the absence of a challenge experiment, leaving the correlate of protection unclear.

mRNA Vaccines: The most cutting-edge approach to BCoV vaccination involves mRNA technology, which has been revolutionized by the COVID-19 pandemic. Two mRNA vaccines targeting the BCoV spike receptor-binding domain (S-RBD), designated XBS01 and XBS02, were developed using AI-optimized coding sequences and encapsulated in lipid nanoparticles. In a mouse model, both vaccines induced robust humoral and cellular immunity, including anti-S-RBD IgG, memory B cells, and T-cell activation. Notably, the XBS02 vaccine was superior to XBS01 in terms of peak antibody titers, memory B-cell frequency, T-cell activation rate, and the secretion of IFN-γ and IL-2, indicating a strong Th1-biased response [56]. This is particularly relevant because a Th1 response is associated with effective antiviral immunity. The mRNA platform offers several theoretical advantages for BCoV control: it can be rapidly updated to match emerging genetic variants, it does not involve live virus, and it can be designed to induce both systemic and mucosal immunity if delivered via appropriate routes. However, the technology remains experimental for veterinary use, and challenges related to cost, cold-chain storage, and large-scale production for livestock populations must be addressed.

Passive Immunization and Immunostimulants: In many management systems, particularly for neonatal calves, passive immunization through colostrum is the most practical and effective means of providing immediate protection. The importance of ensuring adequate transfer of BCoV-specific antibodies via colostrum cannot be overstated. Calves that are colostrum-deprived or that receive colostrum from unvaccinated or unexposed dams are highly susceptible to severe disease [4, 36]. Multivalent vaccines are available to boost maternal antibody levels in the dam, thereby enhancing passive transfer to the calf [58]. Additionally, the use of immunostimulants has been explored as a non-specific means of enhancing resistance. Studies have investigated the use of various immunostimulators to prevent coronavirus disease in calves, with the goal of limiting the use of antibacterial drugs and reducing the emergence of microbial resistance [58]. While these approaches may have a role in integrated management, they are not a substitute for specific immunity induced by vaccination or natural exposure.

The Critical Role of Diagnostics in Surveillance and Outbreak Management

Effective prevention and control are impossible without accurate and timely diagnosis. The ability to detect BCoV in clinical samples, both feces and nasal swabs, is essential for confirming the etiology of outbreaks, monitoring the circulation of virus in a herd, and evaluating the effectiveness of control measures. The World Health Organization (WHO) and WOAH both emphasize the importance of laboratory-based surveillance for emerging and re-emerging infectious diseases, and this principle applies directly to BCoV.

Molecular Diagnostics: Reverse transcription polymerase chain reaction (RT-PCR) has become the gold standard for BCoV detection due to its high sensitivity and specificity. Studies have consistently demonstrated that RT-PCR is significantly more sensitive than antigen-capture ELISA, with nested PCR being up to 5,000 times more sensitive for detecting virus in nasal swab suspensions [18]. This enhanced sensitivity is critical for identifying subclinically infected animals that are shedding virus and contributing to transmission. Real-time RT-PCR (qPCR) assays, including SYBR Green-based methods, have been developed and analytically validated for BCoV, demonstrating satisfactory sensitivity, specificity, and reproducibility [42]. These assays can be multiplexed to simultaneously detect other enteric pathogens such as bovine rotavirus and bovine parvovirus, facilitating differential diagnosis [42].

The development of isothermal amplification assays, such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA), holds promise for barn-side point-of-care testing [45]. These technologies do not require expensive thermocyclers and can be performed with minimal equipment, potentially allowing for rapid on-farm diagnosis and immediate implementation of control measures. However, they require further validation in field settings.

Serological Diagnostics: Serological assays, particularly enzyme-linked immunosorbent assays (ELISAs), are valuable for herd-level surveillance and for assessing vaccine responses. An indirect ELISA based on the recombinant nucleocapsid (N) protein has been developed and shown to have high sensitivity and specificity, with a concordance rate of 94.83% compared to a commercial kit [6]. The N protein is highly conserved among BCoV strains, making it an excellent target for broad-based serological screening [7]. Furthermore, the identification of a linear B-cell epitope (380YQQQDG385) on the N protein that is 100% conserved in BCoV and human coronavirus OC43 but not in other animal coronaviruses [7] provides a potential target for developing epitope-specific diagnostic assays that can distinguish BCoV from other betacoronaviruses.

Antibody-capture ELISAs have been shown to be a better indicator of recent BCoV exposure in adult cattle than virus neutralization tests, particularly when paired serum samples are tested [53]. This is because the ELISA can detect a broader range of antibody isotypes, including IgA, which is important for mucosal immunity. The use of serological monitoring to identify herds with low immunity can guide vaccination strategies and predict the risk of future outbreaks.

Integrated Surveillance Systems: The ultimate goal of diagnostic testing is to inform decision-making. A comprehensive surveillance system for BCoV should integrate molecular and serological testing with epidemiological data. The high prevalence of BCoV in many regions, a meta-analysis of studies in China reported an overall prevalence of 30.8%, with rates as high as 60.5% in South China [9], underscores the need for continuous monitoring. The observation that BCoV can infect a wide range of domestic and wild ruminant species, including water buffalo, sheep, goats, deer, and even odd-toed ungulates like the Indonesian tapir [1, 10, 13, 28], highlights the potential for interspecies transmission and the need for a One Health approach to surveillance. The genetic characterization of circulating strains through sequencing of the S, HE, and N genes is essential for tracking the emergence of new variants, identifying recombination events (such as those documented in the HE gene of Chinese BCoV strains [17]), and ensuring that vaccines remain antigenically matched [21].

Integrated Herd Health Management: A Holistic Approach

No single intervention is sufficient to prevent WD. The most effective control programs are those that integrate biosecurity, vaccination, diagnostics, and supportive management into a cohesive herd health plan. This begins with a thorough risk assessment. Factors such as herd size, housing type (tiestall vs. free-stall), introduction of new animals, and history of previous outbreaks should be evaluated. The finding that pregnant cattle are less likely to develop clinical WD [38] suggests that physiological status may influence susceptibility, and this should be considered in management decisions.

Nutritional management also plays a role. The observation that WD can put cows into negative energy balance, as indicated by increased free fatty acids and an elevated fat-to-protein ratio in milk [35], underscores the importance of maintaining optimal body condition and providing a high-quality diet, particularly during the winter months when the disease is most prevalent. Stress reduction, through proper ventilation, comfortable housing, and minimal handling during outbreaks, can help mitigate the severity of disease.

During an active outbreak, the immediate goals are to limit spread, provide supportive care to affected animals, and minimize economic losses. This involves isolating sick cows, implementing enhanced biosecurity measures, and ensuring adequate fluid and electrolyte therapy for diarrheic animals. The use of antibiotics is not indicated for the viral infection itself but may be necessary to control secondary bacterial infections. The decision to vaccinate during an outbreak is complex; while a live vaccine might theoretically provide rapid protection through interference, the risk of exacerbating disease in incubating animals must be considered.

Long-term control requires a sustained commitment to vaccination, biosecurity, and surveillance. The development of regionally tailored vaccines, informed by ongoing molecular epidemiological studies, is a priority. The emergence of mRNA vaccine technology offers the potential for rapid adaptation to new variants, but its deployment in livestock will require significant investment in infrastructure and regulatory approval. Ultimately, the prevention and control of BCoV winter dysentery will depend on the collective efforts of veterinarians, researchers, and producers to implement evidence-based strategies that are both scientifically sound and practically feasible.

References

[1] Savard C, Provost C, Ariel O, Morin S, Fredrickson R, Gagnon C, et al.. First report and genomic characterization of a bovine-like coronavirus causing enteric infection in an odd-toed non-ruminant species (Indonesian tapir, Acrocodia indica) during an outbreak of winter dysentery in a zoo. Transboundary and Emerging Diseases. 2021. DOI: https://doi.org/10.1111/tbed.14300

[2] Park S, Kim GY, Choy H, Hong Y, Saif LJ, Jeong J, et al.. Dual enteric and respiratory tropisms of winter dysentery bovine coronavirus in calves. Archives of Virology. 2007. DOI: https://doi.org/10.1007/s00705-007-1005-2

[3] Jeong J, Kim G, Yoon S, Park S, Kim Y, Sung C, et al.. Molecular analysis of S gene of spike glycoprotein of winter dysentery bovine coronavirus circulated in Korea during 2002–2003. Virus Research. 2004. DOI: https://doi.org/10.1016/j.virusres.2004.07.003

[4] El-Kanawati Z, Tsunemitsu H, Smith DR, Saif LJ. Infection and cross-protection studies of winter dysentery and calf diarrhea bovine coronavirus strains in colostrum-deprived and gnotobiotic calves.. American Journal of Veterinary Research. 1996. DOI: https://doi.org/10.2460/ajvr.1996.57.01.48

[5] Ko C, Kang M, Lim G, Kim G, Yoon S, Park J, et al.. Molecular Characterization of HE, M, and E Genes of Winter Dysentery Bovine Coronavirus Circulated in Korea During 2002–2003. Virus genes. 2006. DOI: https://doi.org/10.1007/s11262-005-6867-3

[6] Liu Q, Niu X, Jiang L, Zhang G, Wang P, Zhang S, et al.. Establishment of an indirect ELISA method for detecting bovine coronavirus antibodies based on N protein. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1530870

[7] Zhou Y, Zhang J, Wu H, Zhao S, Ren Y, Chen Q, et al.. First linear B-cell epitope identified on the nucleocapsid protein of bovine coronavirus.. Virology. 2025. DOI: https://doi.org/10.1016/j.virol.2025.110581

[8] Park G, Choe S, Song S, Kim K, Shin J, An B, et al.. Characterization and Spike Gene Analysis of a Candidate Attenuated Live Bovine Coronavirus Vaccine. Animals. 2024. DOI: https://doi.org/10.3390/ani14030389

[9] Geng H, Meng X, Yan W, Li X, Jiang J, Ni H, et al.. Prevalence of bovine coronavirus in cattle in China: A systematic review and meta-analysis.. Microbial Pathogenesis. 2023. DOI: https://doi.org/10.1016/j.micpath.2023.106009

[10] Chothe S, Byukusenge M, Sekhwal MK, Li L, LaBella LC, Jakka P, et al.. Complete Genome Sequence of a Bovine Coronavirus Isolated from a Goat in Pennsylvania, USA. Microbiology Resource Announcements. 2023. DOI: https://doi.org/10.1128/mra.00122-23

[11] Glotov A, Nefedchenko AV, Yuzhakov A, Koteneva S, Glotova T, Komina A, et al.. [Genetic diversity of Siberian bovine coronavirus isolates (Coronaviridae: Coronavirinae: Betacoronavirus-1: Bovine-Like coronaviruses)].. Voprosy virusologii. 2023. DOI: https://doi.org/10.36233/0507-4088-141

[12] Cho H, Kim Y, Song J, Cho S, Park M, Kim J, et al.. Experimental intranasal infection reveals broad tissue tropism of bovine coronavirus. Veterinary Research. 2026. DOI: https://doi.org/10.1186/s13567-025-01703-9

[13] Vlasova A, Saif L. Bovine Coronavirus and the Associated Diseases. Frontiers in Veterinary Science. 2021. DOI: https://doi.org/10.3389/fvets.2021.643220

[14] Shin J, Choe S, Park G, Song S, Kim K, An B, et al.. Isolation and Genetic Characterization of a Bovine Coronavirus KBR-1 Strain from Calf Feces in South Korea. Viruses. 2022. DOI: https://doi.org/10.3390/v14112376

[15] Kim E, Cho H, Shin S, Park J, Choi K. Prevalence and genetic characterization of bovine coronavirus identified from diarrheic pre-weaned native Korean calves from 2019 to 2021.. Infection, Genetics and Evolution. 2022. DOI: https://doi.org/10.1016/j.meegid.2022.105263

[16] Kim E, Cho H, Shin S, Park J, Choi K. Genetic Evolution of Bovine Coronavirus Detected in the Republic of Korea. . 2021. DOI: https://doi.org/10.21203/rs.3.rs-631986/v1

[17] Keha A, Xue L, Yan S, Yue H, Tang C. Prevalence of a novel bovine coronavirus strain with a recombinant hemagglutinin/esterase gene in dairy calves in China. Transboundary and Emerging Diseases. 2019. DOI: https://doi.org/10.1111/tbed.13228

[18] Cho K, Hasöksüz M, Nielsen P, Chang K, Lathrop S, Saif L. Cross-protection studies between respiratory and calf diarrhea and winter dysentery coronavirus strains in calves and RT-PCR and nested PCR for their detection. Archives of Virology. 2001. DOI: https://doi.org/10.1007/s007050170011

[19] Tsunemitsu H, Saif L. Antigenic and biological comparisons of bovine coronaviruses derived from neonatal calf diarrhea and winter dysentery of adult cattle. Archives of Virology. 2005. DOI: https://doi.org/10.1007/BF01322757

[20] Beuttemmuller EA, Alfieri A, Headley SA, Alfieri A. Brazilian strain of bovine respiratory coronavirus is derived from dual enteric and respiratory tropism.. Genetics and Molecular Research. 2017. DOI: https://doi.org/10.4238/gmr16029580

[21] Bidokhti M, Tråvén M, Ohlson A, Baule C, Hakhverdyan M, Belák S, et al.. Tracing the transmission of bovine coronavirus infections in cattle herds based on S gene diversity. The Veterinary Journal. 2012. DOI: https://doi.org/10.1016/j.tvjl.2011.12.015

[22] Boileau M, Kapil S. Bovine Coronavirus Associated Syndromes. The Veterinary clinics of North America. Food animal practice. 2010. DOI: https://doi.org/10.1016/j.cvfa.2009.10.003

[23] Takiuchi E, Alfieri A, Alfieri A. Molecular analysis of the bovine coronavirus S1 gene by direct sequencing of diarrheic fecal specimens.. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas. 2008. DOI: https://doi.org/10.1590/S0100-879X2008000400004

[24] Yang D, Kweon C, Kim B, Park J, So B, Song J. Serological Survey of Bovine Coronavirus in Korea. Journal of Bacteriology and Virology. 2007. DOI: https://doi.org/10.4167/JBV.2007.37.2.105

[25] Saif L. Bovine Respiratory Coronavirus. The Veterinary clinics of North America. Food animal practice. 2010. DOI: https://doi.org/10.1016/j.cvfa.2010.04.005

[26] Salem E, Dhanasekaran V, Cassard H, Hause B, Maman S, Meyer G, et al.. Global Transmission, Spatial Segregation, and Recombination Determine the Long-Term Evolution and Epidemiology of Bovine Coronaviruses. Viruses. 2020. DOI: https://doi.org/10.3390/v12050534

[27] Yilmaz S, Yılmaz A, Karadağ G, Turan N, Richt JA, Yilmaz H. Molecular characterization of BCoV infecting vaccinated and non-vaccinated cattle in Thrace district Türkiye and isolation of field strains. Virology Journal. 2025. DOI: https://doi.org/10.1186/s12985-025-03010-3

[28] Larska M, Tomana J, Krzysiak M, Pomorska-Mól M, Socha W. Prevalence of coronaviruses in European bison (Bison bonasus) in Poland. Scientific Reports. 2024. DOI: https://doi.org/10.1038/s41598-024-63717-1

[29] Gélinas A, Boutin M, Sasseville A, Dea S. Bovine coronaviruses associated with enteric and respiratory diseases in Canadian dairy cattle display different reactivities to anti-HE monoclonal antibodies and distinct amino acid changes in their HE, S and ns4.9 protein. Virus Research. 2001. DOI: https://doi.org/10.1016/S0168-1702(01)00243-X

[30] Hasoksuz M, Vlasova A, Saif L. Detection of Group 2a Coronaviruses with Emphasis on Bovine and Wild Ruminant Strains. Methods in molecular biology. 2007. DOI: https://doi.org/10.1007/978-1-59745-181-9_5

[31] David D, Storm N, Ilan W, Sol A. Characterization of Winter Dysentery Bovine Coronavirus Isolated from Cattle in Israel. Viruses. 2021. DOI: https://doi.org/10.3390/v13061070

[32] Takiuchi E, Barry AF, Alfieri A, Filippsen P, Alfieri A. An outbreak of winter dysentery caused by bovine coronavirus in a high-production dairy cattle herd from a tropical country. Brazilian Archives of Biology and Technology. 2009. DOI: https://doi.org/10.1590/S1516-89132009000700008

[33] Amoroso M, Lucifora G, Uberti BĎ, Serra F, Luca Gd, Borriello G, et al.. Fatal Interstitial Pneumonia Associated with Bovine Coronavirus in Cows from Southern Italy. Viruses. 2020. DOI: https://doi.org/10.3390/v12111331

[34] Chae J, Park J, Jung S, Kang J, Chae J, Choi K. Acute phase response in bovine coronavirus positive post-weaned calves with diarrhea. Acta Veterinaria Scandinavica. 2019. DOI: https://doi.org/10.1186/s13028-019-0471-3

[35] Toftaker I, Holmøy I, Nødtvedt A, Østerås O, Stokstad M. A cohort study of the effect of winter dysentery on herd-level milk production. Journal of Dairy Science. 2017. DOI: https://doi.org/10.3168/jds.2017-12605

[36] Tråvén M, Näslund K, Linde N, Linde B, Silván A, Fossum C, et al.. Experimental reproduction of winter dysentery in lactating cows using BCV , comparison with BCV infection in milk-fed calves. Veterinary Microbiology. 2001. DOI: https://doi.org/10.1016/S0378-1135(01)00337-6

[37] Natsuaki S, Goto K, Nakamura K, Yamada M, Ueo H, Komori T, et al.. Fatal winter dysentery with severe anemia in an adult cow.. Journal of Veterinary Medical Science. 2007. DOI: https://doi.org/10.1292/JVMS.69.957

[38] Smith DR, Fedorka-Cray P, Mohan R, Brock K, Wittum T, Morley P, et al.. Evaluation of cow-level risk factors for the development of winter dysentery in dairy cattle.. American Journal of Veterinary Research. 1998. DOI: https://doi.org/10.2460/ajvr.1998.59.08.986

[39] Clark M. Bovine coronavirus. British Veterinary Journal. 2007. DOI: https://doi.org/10.1016/S0007-1935(05)80210-6

[40] Nakagawa K, Kumano H, Kitamura Y, Kuwata K, Tanaka E, Fukushi H. Complete Genome Sequence of Bovine Coronavirus in Blood Diarrhea from Adult Cattle That Died from Winter Dysentery in Japan. Microbiology Resource Announcements. 2021. DOI: https://doi.org/10.1128/MRA.00807-21

[41] Valle M, Batista ER, Martell A, Lepuroux MTF, Brandão P. Short communication. First report in Cuba of bovine coronavirus detection in a winter dysentery outbreak. Spanish Journal of Agricultural Research. 2014. DOI: https://doi.org/10.5424/SJAR/2006043-6300

[42] Zhang S, Ma H, Zhao J, Yu K, Hao J, Yu H, et al.. First Isolation of Bovine Coronavirus From Yanbian, China, and Analytical Validation of a SYBR Green I RT‐qPCR Panel for Calf Diarrhea Viruses. Transboundary and Emerging Diseases. 2026. DOI: https://doi.org/10.1155/tbed/6648536

[43] Tsunemitsu H, Smith DR, Saif L. Experimental inoculation of adult dairy cows with bovine coronavirus and detection of coronavirus in feces by RT-PCR. Archives of Virology. 2014. DOI: https://doi.org/10.1007/s007050050493

[44] Ribeiro J, Lorenzetti E, Alfieri A, Alfieri A. Molecular detection of bovine coronavirus in a diarrhea outbreak in pasture-feeding Nellore steers in southern Brazil. Tropical Animal Health and Production. 2015. DOI: https://doi.org/10.1007/s11250-015-0975-4

[45] . Advances in Laboratory Diagnosis of Coronavirus Infections in Cattle. Pathogens. 2024. DOI: https://doi.org/10.3390/pathogens13070524

[46] Smith DR, Fedorka-Cray P, Mohan R, Brock KV, Wittum T, Morley P, et al.. Epidemiologic herd-level assessment of causative agents and risk factors for winter dysentery in dairy cattle.. American Journal of Veterinary Research. 1998. DOI: https://doi.org/10.2460/ajvr.1998.59.08.994

[47] Brandão P, Villarreal L, Gregori F, Souza S, Lopes MA, Gomes CR, et al.. On the etiology of an outbreak of winter dysentery in dairy cows in Brazil. Pesquisa Veterinaria Brasileira. 2007. DOI: https://doi.org/10.1590/S0100-736X2007001000002

[48] Jeong J, Kim G, Yoon S, Park S, Kim Y, Sung C, et al.. Detection and isolation of winter dysentery bovine coronavirus circulated in Korea during 2002-2004.. Journal of Veterinary Medical Science. 2005. DOI: https://doi.org/10.1292/JVMS.67.187

[49] Brandão P, Gregori F, Sforsin AJ, Villarreal L, Jerez JA. Winter dysentery in cows associated with Bovine Coronavirus (BCoV). Arquivo Brasileiro De Medicina Veterinaria E Zootecnia. 2007. DOI: https://doi.org/10.1590/S0102-09352007000400038

[50] Pratelli A, Capozza P, Minesso S, Lucente M, Pellegrini F, Tempesta M, et al.. Humoral Immune Response in Immunized Sheep with Bovine Coronavirus Glycoproteins Delivered via an Adenoviral Vector. Pathogens. 2024. DOI: https://doi.org/10.3390/pathogens13070523

[51] El-Mohamady R. SEROLOGICAL DIAGNOSIS OF BOVINE CORONAVIRUS IN CALVES USING A DEVELOPMENT NATIVE ELISA PREPARATION. Assiut veterinary medical journal. 2021. DOI: https://doi.org/10.21608/avmj.2021.177854

[52] Alfieri A, Alfieri A, Takiuchi E. Detection of Bovine Coronavirus by Conventional Reverse Transcription Polymerase Chain Reaction. Animal Coronaviruses. 2015. DOI: https://doi.org/10.1007/978-1-4939-3414-0_9

[53] Smith DR, Nielsen P, Gadfield KL, Saif LJ. Further validation of antibody-capture and antigen-capture enzyme-linked immunosorbent assays for determining exposure of cattle to bovine coronavirus.. American Journal of Veterinary Research. 1998. DOI: https://doi.org/10.2460/ajvr.1998.59.08.956

[54] Min F, Liang Y, Jiang Q, Tao X, Wan J, Xue T, et al.. Isolation, identification and pathogenicity analysis of BCoV epidemic strains in Xinjiang. Frontiers in Microbiology. 2026. DOI: https://doi.org/10.3389/fmicb.2026.1788466

[55] Hasöksüz M, Lathrop S, Al-dubaib M, Lewis P, Saif L. Antigenic variation among bovine enteric coronaviruses (BECV) and bovine respiratory coronaviruses (BRCV) detected using monoclonal antibodies. Archives of Virology. 2014. DOI: https://doi.org/10.1007/s007050050656

[56] Liu S, Gong Z, Wang P, Chen F, Fu X, Fan H, et al.. Preparation and Immunological Efficacy Evaluation of mRNA Vaccines Targeting the Spike Protein of Bovine Coronavirus. Vaccines. 2025. DOI: https://doi.org/10.3390/vaccines13111155

[57] Hodnik J, Ježek J, Starič J. Coronaviruses in cattle. Tropical Animal Health and Production. 2020. DOI: https://doi.org/10.1007/s11250-020-02354-y

[58] Zeynalova S, Abbasov V, Bagirzade B. Use of Immunostimulators in the Prevention of Coronavirus Disease in Calves. Bulletin of Science and Practice. 2024. DOI: https://doi.org/10.33619/2414-2948/101/29